This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to the government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Centene is now a $100-billion plus enterprise catering healthcare services to more than 24 million members across 50 states. The recent acquisition of WellCare Health leveraged the company’s position as the largest Medicaid managed care organization in the country. The combined entity now has 22 million members. In 2019, the company retained its market-leading position nationwide, serving 1.8 million exchange members across 20 states at the year-end.
Centene (CNC) Down 8.3% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Centene (CNC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights UnitedHealth, Elevance Health, Humana and Centene
by Zacks Equity Research
UnitedHealth, Elevance Health, Humana and Centene are included in this Analyst Blog.
Will Biden's Tax Hike Plan Extend Medicare's Life to 2050?
by Kaibalya Pravo Dey
U.S. President Joe Biden's proposal is also likely to enhance Medicare's ability to negotiate prices for drugs.
Centene (CNC) Stock Moves -1.46%: What You Should Know
by Zacks Equity Research
Centene (CNC) closed at $67.95 in the latest trading session, marking a -1.46% move from the prior day.
Centene (CNC) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Centene (CNC) closed at $68.51 in the latest trading session, marking a +0.16% move from the prior day.
Why Centene (CNC) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Tenet (THC) Q4 Earnings Beat on Ambulatory Care Strength
by Zacks Equity Research
Tenet Healthcare's (THC) bottom line deteriorates due to higher operating expenses, partially offset by an improving Ambulatory Care segment.
Should Vanguard Mid-Cap Value ETF (VOE) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VOE
Centene (CNC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Centene (CNC) give insight into how the company performed in the quarter ended December 2022, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Centene (CNC) Q4 Earnings Miss on High Costs, '23 Premium View Up
by Zacks Equity Research
Centene's (CNC) fourth-quarter results suffer from elevated medical expenses, partly offset by growing premium and service revenues.
Centene (CNC) Q4 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Centene (CNC) delivered earnings and revenue surprises of -1.15% and 0.08%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Can Lower Managed Care Profits Hurt Centene (CNC) Q4 Earnings?
by Zacks Equity Research
Centene's (CNC) fourth-quarter results are likely to reflect growth in premiums and memberships.
Humana (HUM) Tops Q4 Earnings Estimates
by Zacks Equity Research
Humana (HUM) delivered earnings and revenue surprises of 10.96% and 0.12%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Centene (CNC) Stock Moves -0.73%: What You Should Know
by Zacks Equity Research
In the latest trading session, Centene (CNC) closed at $74.70, marking a -0.73% move from the previous day.
The Zacks Analyst Blog Highlights AstraZeneca, NextEra Energy, The Boeing, The PNC Financial Services Group and Centene
by Zacks Equity Research
AstraZeneca, NextEra Energy, The Boeing, The PNC Financial Services Group and Centene are part of the Zacks top Analyst Blog.
Top Analyst Reports for AstraZeneca, NextEra Energy & Boeing Company
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including AstraZeneca PLC (AZN), NextEra Energy, Inc. (NEE) and The Boeing Company (BA).
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Should Vanguard MidCap ETF (VO) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VO
Should IQ Chaikin U.S. Large Cap ETF (CLRG) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for CLRG
Is IQ Chaikin U.S. Large Cap ETF (CLRG) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for CLRG
Community Health (CYH) Sells Hospital, Renews Health Net Tie-Up
by Zacks Equity Research
Community Health (CYH) announces the divestiture of its West Virginia hospital and the expansion of its alliance with Health Net, thereby undertaking initiatives to boost business prospects.
Centene (CNC) Wins Contract From DHCS to Serve Medi-Cal Members
by Zacks Equity Research
Centene's (CNC) California subsidiary receives a contract from the DHCS to better address the health requirements of the state's Medi-Cal members.
Molina's (MOH) California Medicaid Revenues to Double in 2024
by Zacks Equity Research
Molina Healthcare (MOH) expects combined revenues from California, Nebraska, and Iowa in 2024 to reach $4.2 billion.
Why Hold Strategy is Apt for Centene (CNC) Stock Right Now
by Zacks Equity Research
Centene's (CNC) health benefits ratio is expected to improve in the coming days, signaling better operating efficiency.
5 Broker-Friendly Stocks to Bank On as Volatility Persists
by Maharathi Basu
Broker-favorite stocks like Cardinal Health (CAH), American Airlines (AAL), Boise Cascade (BCC), AmerisourceBergen (ABC) and Centene (CNC) should be on an investors' watchlist.